ATE152722T1 - Verfahren zur herstellung von 9-(2-hydroxy)- ethoxy-guanin - Google Patents
Verfahren zur herstellung von 9-(2-hydroxy)- ethoxy-guaninInfo
- Publication number
- ATE152722T1 ATE152722T1 AT94906897T AT94906897T ATE152722T1 AT E152722 T1 ATE152722 T1 AT E152722T1 AT 94906897 T AT94906897 T AT 94906897T AT 94906897 T AT94906897 T AT 94906897T AT E152722 T1 ATE152722 T1 AT E152722T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- guanine
- ethoxy
- hydroxy
- producing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT93RM000608A IT1266486B1 (it) | 1993-09-10 | 1993-09-10 | Procedimento per la preparazione della 9-(2-idrossi)etossimetil- guanina. |
| IT93MI002324A IT1266654B1 (it) | 1993-11-03 | 1993-11-03 | Procedimento per la purificazione della 9-(2-idrossi) etossimetilguanina |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE152722T1 true ATE152722T1 (de) | 1997-05-15 |
Family
ID=26331057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94906897T ATE152722T1 (de) | 1993-09-10 | 1994-02-03 | Verfahren zur herstellung von 9-(2-hydroxy)- ethoxy-guanin |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5756737A (de) |
| EP (1) | EP0717744B1 (de) |
| JP (1) | JPH09502707A (de) |
| CN (1) | CN1041632C (de) |
| AT (1) | ATE152722T1 (de) |
| AU (1) | AU685774B2 (de) |
| BG (1) | BG61569B1 (de) |
| BR (1) | BR9407426A (de) |
| CA (1) | CA2171283A1 (de) |
| DE (1) | DE69403087T2 (de) |
| DK (1) | DK0717744T3 (de) |
| ES (1) | ES2103575T3 (de) |
| FI (1) | FI961054A7 (de) |
| GR (1) | GR3024343T3 (de) |
| HU (1) | HU214841B (de) |
| NO (1) | NO960927D0 (de) |
| NZ (1) | NZ261573A (de) |
| PL (1) | PL174765B1 (de) |
| RU (1) | RU2125570C1 (de) |
| SK (1) | SK29396A3 (de) |
| WO (1) | WO1995007281A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19536164A1 (de) * | 1995-09-28 | 1997-04-03 | Boehringer Ingelheim Kg | Verbessertes Verfahren zur Herstellung von 9-[(2-Hyroxyethoxy)methyl]guanin (Acyclovir) |
| IN179493B (de) * | 1996-02-22 | 1997-10-11 | Lupin Laboraties Ltd | |
| EP0976751A1 (de) * | 1996-04-09 | 2000-02-02 | Lupin Laboratories Limited | Ein Verfahren zur Isomerisierung von einem N-7 Isomer in einem N-9 Isomer verwendbar in der Synthese von acyclischen Nucleosiden |
| US6440980B1 (en) * | 1996-09-17 | 2002-08-27 | Avanir Pharmaceuticals | Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs |
| US20050176956A1 (en) * | 2001-10-15 | 2005-08-11 | Babu Jayachandra S. | Process for the preparation of ganciclovir intermediate n2-acetyl-9-(1,3-diacetoxy-2-propoxymethyl) guanine |
| CA2421026C (en) * | 2001-10-16 | 2005-02-15 | Avanir Pharmaceuticals | Viral inhibition by n-docosanol |
| US7078524B2 (en) * | 2002-11-22 | 2006-07-18 | Ranbaxy Laboratories Limited | Process for the synthesis of ganciclovir |
| ES2289650T3 (es) * | 2004-03-03 | 2008-02-01 | Chemi S.P.A. | Sal monosodica del acido 3-piridil-1-hidroxietiliden-1,1-bifosfonico amorfa y procedimiento para la preparacion de la misma. |
| US7700694B2 (en) * | 2006-04-28 | 2010-04-20 | Tsrc Corporation | Catalyst composition and method for hydrogenating a polymer having a conjugated diene |
| CN117551100B (zh) * | 2024-01-12 | 2024-03-12 | 苏州诺维康生物科技有限公司 | (s)-9-[3-(4,4'-双甲氧基三苯甲基)-2-羟基丙基]-n2-乙酰基鸟嘌呤的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4146715A (en) * | 1975-08-27 | 1979-03-27 | Burroughs Wellcome Co. | 2-amido-9-(2-acyloxyethoxymethyl)hypoxanthines |
| YU41079B (en) * | 1976-08-27 | 1986-12-31 | Wellcome Found | Process for the synthesis of substituted purine compounds |
| US4816447A (en) * | 1981-08-26 | 1989-03-28 | Merck & Co., Inc. | Anti-viral guanine compounds |
| US4609661A (en) * | 1982-08-09 | 1986-09-02 | Syntex (U.S.A.) Inc. | Substituted 9-(1-O- or 3-O-monosubstituted or 1,3-di-O-substituted propoxymethyl)purines as antiviral agents |
| JPS5980685A (ja) * | 1982-10-29 | 1984-05-10 | Fujisawa Pharmaceut Co Ltd | N−低級アルカノイルグアニン誘導体およびそれを用いる方法 |
| YU45690B (sh) * | 1984-12-22 | 1992-07-20 | Krka Tovarna Zdraviln.Sol.O. | Postopek za pripravo 9-(2-hidroksietoksimetil)-gvanina |
| SU1705296A1 (ru) * | 1988-03-31 | 1992-01-15 | Институт Органического Синтеза Ан Латвсср | Способ получени 9-(2-оксиэтоксиметил)гуанина |
| JP3225545B2 (ja) * | 1991-09-18 | 2001-11-05 | 味の素株式会社 | 非環状ヌクレオシド類の製造法 |
-
1994
- 1994-02-03 PL PL94313322A patent/PL174765B1/pl unknown
- 1994-02-03 HU HU9600556A patent/HU214841B/hu not_active IP Right Cessation
- 1994-02-03 BR BR9407426A patent/BR9407426A/pt not_active Application Discontinuation
- 1994-02-03 AU AU60383/94A patent/AU685774B2/en not_active Ceased
- 1994-02-03 US US08/602,789 patent/US5756737A/en not_active Expired - Fee Related
- 1994-02-03 DK DK94906897.7T patent/DK0717744T3/da active
- 1994-02-03 JP JP7508403A patent/JPH09502707A/ja active Pending
- 1994-02-03 CA CA002171283A patent/CA2171283A1/en not_active Abandoned
- 1994-02-03 WO PCT/EP1994/000308 patent/WO1995007281A1/en not_active Ceased
- 1994-02-03 CN CN94193288A patent/CN1041632C/zh not_active Expired - Fee Related
- 1994-02-03 FI FI961054A patent/FI961054A7/fi unknown
- 1994-02-03 SK SK293-96A patent/SK29396A3/sk unknown
- 1994-02-03 DE DE69403087T patent/DE69403087T2/de not_active Expired - Fee Related
- 1994-02-03 ES ES94906897T patent/ES2103575T3/es not_active Expired - Lifetime
- 1994-02-03 RU RU96107229A patent/RU2125570C1/ru active
- 1994-02-03 EP EP94906897A patent/EP0717744B1/de not_active Expired - Lifetime
- 1994-02-03 AT AT94906897T patent/ATE152722T1/de not_active IP Right Cessation
- 1994-02-03 NZ NZ261573A patent/NZ261573A/en unknown
-
1996
- 1996-03-04 BG BG100395A patent/BG61569B1/bg unknown
- 1996-03-07 NO NO960927A patent/NO960927D0/no unknown
-
1997
- 1997-07-31 GR GR970401990T patent/GR3024343T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69403087T2 (de) | 1997-08-14 |
| WO1995007281A1 (en) | 1995-03-16 |
| EP0717744B1 (de) | 1997-05-07 |
| JPH09502707A (ja) | 1997-03-18 |
| NO960927L (no) | 1996-03-07 |
| NO960927D0 (no) | 1996-03-07 |
| FI961054A0 (fi) | 1996-03-07 |
| CN1130382A (zh) | 1996-09-04 |
| HUT74295A (en) | 1996-11-28 |
| NZ261573A (en) | 1997-02-24 |
| FI961054L (fi) | 1996-03-07 |
| FI961054A7 (fi) | 1996-03-07 |
| AU685774B2 (en) | 1998-01-29 |
| BG100395A (bg) | 1996-09-30 |
| CN1041632C (zh) | 1999-01-13 |
| RU2125570C1 (ru) | 1999-01-27 |
| DE69403087D1 (de) | 1997-06-12 |
| BG61569B1 (en) | 1997-12-30 |
| HU214841B (hu) | 1998-06-29 |
| PL174765B1 (pl) | 1998-09-30 |
| PL313322A1 (en) | 1996-06-24 |
| ES2103575T3 (es) | 1997-09-16 |
| DK0717744T3 (da) | 1997-12-08 |
| AU6038394A (en) | 1995-03-27 |
| SK29396A3 (en) | 1996-10-02 |
| HU9600556D0 (en) | 1996-05-28 |
| BR9407426A (pt) | 1996-04-09 |
| CA2171283A1 (en) | 1995-03-16 |
| US5756737A (en) | 1998-05-26 |
| EP0717744A1 (de) | 1996-06-26 |
| GR3024343T3 (en) | 1997-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69716767D1 (de) | Verfahren zur herstellung von tolterodin | |
| PA8464901A1 (es) | Procesos para la sintesis de 1,3-dioles | |
| DE69713374D1 (de) | Verfahren zur herstellung von optisch reinen isomeren des formoterols | |
| ATE176472T1 (de) | Verfahren zur herstellung von nalbuphin das wenig des 6-beta-epimers enthält | |
| DE69104365D1 (de) | Vaterit und verfahren zu dessen herstellung. | |
| DE69403087D1 (de) | Verfahren zur herstellung von 9-(2-hydroxy)-ethoxy-guanin | |
| DE69007389D1 (de) | Verfahren zur Herstellung von Schleifmitteln. | |
| DE69109526D1 (de) | Verfahren zur Herstellung von Dimethylnaphthalen. | |
| DE59300418D1 (de) | Verfahren zur Herstellung von natürlichen Antioxidantien. | |
| ATE114300T1 (de) | Verfahren zur herstellung von albuterol, sowie von arylglyoxal-, acetal-, hemiacetal- und hydrat-zwischenprodukten. | |
| GB9108056D0 (en) | Synthetic antigen | |
| DE69418260D1 (de) | Verfahren zur Herstellung von L-3,4-Dihydroxyphenylalanin | |
| DE69013621D1 (de) | Verfahren zur Herstellung von tertiärem Amino-Alkohol. | |
| DE69026585D1 (de) | Verfahren zur Herstellung von R-(-)-3-Halogeno-1,2-propandiol durch Behandlung mit Mikroorganismen | |
| DE58902228D1 (de) | Verfahren zur herstellung von 5-gliedrigen, stickstoffhaltigen heteroaromaten. | |
| DE68922507D1 (de) | Verfahren zur Herstellung von beta-2',2'-Difluornukleosiden. | |
| DE3869885D1 (de) | Verfahren zur herstellung des gereinigten naphthalin-2,6-dicarbonsaeure-bis (2-hydroxyethyl)-esters. | |
| DE69022014D1 (de) | Verfahren zur Herstellung von S-(+)-3-Halogeno-1,2-propandiol durch Behandlung mit Mikroorganismen. | |
| DE3750610D1 (de) | Verfahren zur Herstellung dünnflüssiger Amphotenside. | |
| ATE148694T1 (de) | Verfahren zur herstellung von 3(5)- methylpyrazolen | |
| DE69016922D1 (de) | Verfahren zur Herstellung von 17-Estern des 21-Desoxyprednisolons. | |
| DE69514512D1 (de) | Verfahren zur herstellung von benzopyranderivaten | |
| DE69618340D1 (de) | Verfahren zur herstellung von substituierten anthrachinonen und deren verwendung zur herstellung von rheinen | |
| DE69410898D1 (de) | Verfahren zur herstellung von n,n,-disubstituiertem aminophenol | |
| DE59106495D1 (de) | Verfahren zur herstellung von isopropylnaphthalin. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |